Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

Freenome, Inc.

NotesSupport
aboutterms

Institutional HoldersBeta

Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.

Freenome, Inc.

CIK 0002017526FRNM· quarter ending 2026-06-30
Shares outstanding
10,313,492
as of 2026-07-15 · 10-Q cover page, filed 2026-07-15
Held by 13F filers
8,894,812
109.0% of Common Class A
Holders
27
-7 vs 2026-03-31 · 7 new, 14 exited
Value
$96.8M
shares -12.1% vs prior quarter
13F holdings exceed the share count. This is normal for heavily shorted stocks: shares lent to short sellers are reported by the lender and again by whoever bought them. Related filers occasionally report the same position twice as well.

Share classes (cover page of the 10-Q filed 2026-07-15, as of 2026-07-15)

ClassListedShares outstandingHeld by 13F filers% of classHoldersCUSIP
Common Class APCSC · NASDAQ8,157,2428,894,812109.0%27G70077105
Common Class Bnot listed2,156,250——

Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.

Securities (CUSIPs held in 13F this quarter)

tick to combine
CountCUSIPClass (as filers write it)HoldersShares heldClass shares% of classValueOptionsMapped via
G70077105CL A ORD SHS278,894,8128,157,242109.0%$96.8M—13DGholders →

Totals combine the ticked CUSIPs and update as you tick: common-stock classes by default; preferreds, notes, warrants and depositary shares are listed but not counted. "holders →" shows a single CUSIP on its own. Bonds are held as a principal amount, not shares. Options positions are never counted as holdings. 1 further CUSIPs map to this company (mostly bonds) but no 13F filer held them this quarter.

Top holders (27 of 27 · G70077105)

change vs 2026-03-31
#FilerShares% of classValueChange
1FARALLON CAPITAL MANAGEMENT, L.L.C.2,250,00027.58%$24.5M—
2One Fin Capital Management LP843,48210.34%$9.2M—
3RA CAPITAL MANAGEMENT, L.P.750,0009.19%$8.2M—
4RTW INVESTMENTS, LP742,5009.10%$8.1M—
5ADAR1 Capital Management, LLC674,6958.27%$7.3M+175,114 (+35.1%)
6HIGHBRIDGE CAPITAL MANAGEMENT LLC661,4938.11%$7.2MNEW
7Holocene Advisors, LP604,0507.41%$6.6M-21,123 (-3.4%)
8Aberdeen Group plc578,5657.09%$6.3M—
9Sculptor Capital LP424,7005.21%$4.6M—
10Shay Capital LLC213,9122.62%$2.3M+62,928 (+41.7%)
11CRCM LP194,5302.38%$2.1M+78,285 (+67.3%)
12K2 PRINCIPAL FUND, L.P.182,1242.23%$2.0MNEW
13FNY Investment Advisers, LLC160,4651.97%$1.7M+95,095 (+145.5%)
14Lighthouse Investment Partners, LLC160,0001.96%$1.7M+9,250 (+6.1%)
15BIT Capital GmbH120,0001.47%$1.3M-620,264 (-83.8%)
16MILLENNIUM MANAGEMENT LLC62,2640.76%$677K—
17Alpha Wave Global, LP51,6830.63%$562K-105,305 (-67.1%)
18SUSQUEHANNA INTERNATIONAL GROUP, LLP49,8730.61%$543K+36,022 (+260.1%)
19Eagle Health Investments LP37,6860.46%$410K—
20Shaolin Capital Management LLC37,2600.46%$405K+12,260 (+49.0%)
21Harraden Circle Investments, LLC35,7430.44%$389KNEW
22MOORE CAPITAL MANAGEMENT, LP25,0000.31%$272K—
23CITADEL ADVISORS LLC16,4540.20%$179KNEW
24HRT FINANCIAL LP13,8870.17%$151K+2,842 (+25.7%)
25UBS Group AG3,8420.05%$42KNEW
26US BANCORP \DE\6030.01%$7KNEW
27MORGAN STANLEY10.00%$11NEW
Exited since 2026-03-31 (14 filers; largest 14 shown)
683 Capital Management, LLC−561,923
Empyrean Capital Partners, LP−282,100
Ikarian Capital, LLC−240,951
Balyasny Asset Management L.P.−162,434
BOOTHBAY FUND MANAGEMENT, LLC−161,437
DLD Asset Management, LP−126,083
LMR Partners LLP−117,421
Lineage Point Capital LP−80,258
Longaeva Partners L.P.−36,614
J. Goldman & Co LP−31,428
Virtu Financial LLC−23,234
Schonfeld Strategic Advisors LLC−15,030
READYSTATE ASSET MANAGEMENT LP−10,987
Allworth Financial LP−300

Large holders from 13D/13G (latest per reporting person, last 2 years)

Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.

Reporting personFormFiledEventShares% of class
Roche Finance LtdSCHEDULE 13G2026-09-012026-07-2018,692,76617.4%
Roche Holdings, Inc.SCHEDULE 13G2026-09-012026-07-2018,692,76617.4%
Roche Holding LtdSCHEDULE 13G2026-09-012026-07-2018,692,76617.4%
ADAR1 Capital Management GP, LLCSCHEDULE 13G/A2026-08-142026-06-30494,4496.1%
ADAR1 Capital Management, LLCSCHEDULE 13G/A2026-08-142026-06-30674,6958.3%
Highbridge Capital Management, LLCSCHEDULE 13G2026-08-142026-06-3000%
Daniel SchneebergerSCHEDULE 13G/A2026-08-142026-06-30674,6958.3%
683 Capital Partners, LPSCHEDULE 13G/A2026-08-122026-06-3000%
Ari ZweimanSCHEDULE 13G/A2026-08-122026-06-3000%
IPConcept (Luxemburg) S.A.SCHEDULE 13G/A2026-08-122026-06-3000%
BIT Global Technology Opportunities SICAV-FISSCHEDULE 13G/A2026-08-122026-06-3000%
683 Capital Management, LLCSCHEDULE 13G/A2026-08-122026-06-3000%
BIT Capital GmbHSCHEDULE 13G/A2026-08-052026-06-30120,0001.2%
Andreessen Horowitz LSV Fund II, L.P.SCHEDULE 13G2026-07-272026-07-201,038,8141%
Benjamin A. HorowitzSCHEDULE 13G2026-07-272026-07-205,571,5995.2%
AH Parallel Fund IV, L.P.SCHEDULE 13G2026-07-272026-07-201,199,0531.1%
AH Equity Partners V, L.L.C.SCHEDULE 13G2026-07-272026-07-206,2070%
Marc L. AndreessenSCHEDULE 13G2026-07-272026-07-205,571,5995.2%
AH Bio Fund I, L.P.SCHEDULE 13G2026-07-272026-07-203,327,5253.1%
CLF Partners, LPSCHEDULE 13G2026-07-272026-07-206,2070%
AH Equity Partners Bio I, L.L.C.SCHEDULE 13G2026-07-272026-07-203,327,5253.1%
AH Equity Partners IV (Parallel), L.L.C.SCHEDULE 13G2026-07-272026-07-201,199,0531.1%
AH Equity Partners LSV II, L.L.C.SCHEDULE 13G2026-07-272026-07-201,038,8141%
Perceptive Life Sciences Master Fund, Ltd.SCHEDULE 13G2026-07-232026-07-2010,871,84710.1%
Perceptive Advisors LLCSCHEDULE 13G2026-07-232026-07-2010,871,84710.1%
Joseph EdelmanSCHEDULE 13G2026-07-232026-07-2010,871,84710.1%
Peter KolchinskySCHEDULE 13D/A2026-07-222026-07-2015,367,27014.3%
RA Capital Management, L.P.SCHEDULE 13D/A2026-07-222026-07-2015,367,27014.3%
Rajeev ShahSCHEDULE 13D/A2026-07-222026-07-2015,367,27014.3%
RA Capital Healthcare Fund, L.P.SCHEDULE 13D/A2026-07-222026-07-2012,230,12211.4%
Point72 Asset Management, L.P.SCHEDULE 13G2026-07-082026-07-07465,0005.7%
Point72 Capital Advisors, Inc.SCHEDULE 13G2026-07-082026-07-07465,0005.7%
Steven A. CohenSCHEDULE 13G2026-07-082026-07-07465,0005.7%
David MacKnightSCHEDULE 13G/A2026-05-152026-03-31843,4829.5%
One Fin Capital Master Fund LPSCHEDULE 13G/A2026-05-152026-03-31843,4829.5%
One Fin Capital GP LLCSCHEDULE 13G/A2026-05-152026-03-31843,4829.5%
One Fin Capital Management LPSCHEDULE 13G/A2026-05-152026-03-31843,4829.5%
CRCM LPSCHEDULE 13G/A2026-05-132026-03-31116,2451.3%
Chun R. DingSCHEDULE 13G/A2026-05-132026-03-31116,2451.3%
CRCM INSTITUTIONAL MASTER FUND (BVI), LTD.SCHEDULE 13G/A2026-05-132026-03-3199,6001.1%
CRCM LLCSCHEDULE 13G/A2026-05-132026-03-31116,2451.3%
abrdn Inc.SCHEDULE 13G2026-04-282026-04-01578,5656.49%
Aberdeen Group plcSCHEDULE 13G2026-04-282026-04-01578,5656.49%
Commodore Capital Master LPSCHEDULE 13G/A2026-02-172025-12-3100%
Holocene Advisors, LPSCHEDULE 13G2026-02-172025-12-31625,1737.02%
Commodore Capital LPSCHEDULE 13G/A2026-02-172025-12-3100%
Nimish ShahSCHEDULE 13G/A2026-02-172025-12-3100%
J. Brandon HaleySCHEDULE 13G2026-02-172025-12-31625,1737.02%
Bong Y. KohSCHEDULE 13G/A2026-02-172025-12-3100%
Venrock Healthcare Capital Partners EG, L.P.SCHEDULE 13G/A2026-02-172025-12-3100%
Venrock Healthcare Capital Partners III, L.P.SCHEDULE 13G/A2026-02-172025-12-3100%
VHCP Co-Investment Holdings III, LLCSCHEDULE 13G/A2026-02-172025-12-3100%
VHCP Management EG, LLCSCHEDULE 13G/A2026-02-172025-12-3100%
VHCP Management III, LLCSCHEDULE 13G/A2026-02-172025-12-3100%
IPCONCEPT (LUXEMBOURG) S.A.SCHEDULE 13G2026-02-112025-12-08620,2647%

Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.